{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.90 vs. cons $4.79",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Enterprise revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.75B vs. cons $3.72B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "BLS quarterly book-to-bill",
      "prediction": "BEAT",
      "answer": "pred ~1.02x vs. cons 1.00x",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$18.20 vs. cons $18.00 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 enterprise revenue midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$14.78B vs. cons $14.71B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 free cash flow midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$1.34B vs. cons $1.30B (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "LOW",
  "day5_residual_pct": 2.6,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~$4.90 Q2 EPS result and ~$18.20 FY2026 midpoint imply roughly $9.05 of second-half EPS versus approximately $8.96 embedded in current consensus, supporting modest positive revisions after the initial reaction; the strong pre-report rally limits the magnitude.",
  "day5_confidence": "LOW"
}